Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated (Q44409689)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 June 2013
edit
Language Label Description Also known as
English
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated
scientific article published on 18 June 2013

    Statements

    Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated (English)
    Li-juan Shi
    Guang-yao Song
    He-fang Zhang
    Zhi-juan Hu
    Chao Wang
    Dong-hui Zhang
    18 June 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit